Ardelyx Inc (ARDX)
5.66
-0.23
(-3.90%)
USD |
NASDAQ |
Nov 05, 10:28
Ardelyx Enterprise Value: 1.305B for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 1.305B |
| November 01, 2024 | 1.353B |
| October 31, 2024 | 1.301B |
| October 30, 2024 | 1.305B |
| October 29, 2024 | 1.334B |
| October 28, 2024 | 1.308B |
| October 25, 2024 | 1.277B |
| October 24, 2024 | 1.298B |
| October 23, 2024 | 1.232B |
| October 22, 2024 | 1.280B |
| October 21, 2024 | 1.303B |
| October 18, 2024 | 1.294B |
| October 17, 2024 | 1.291B |
| October 16, 2024 | 1.296B |
| October 15, 2024 | 1.325B |
| October 14, 2024 | 1.329B |
| October 11, 2024 | 1.341B |
| October 10, 2024 | 1.341B |
| October 09, 2024 | 1.301B |
| October 08, 2024 | 1.322B |
| October 07, 2024 | 1.362B |
| October 04, 2024 | 1.526B |
| October 03, 2024 | 1.488B |
| October 02, 2024 | 1.552B |
| October 01, 2024 | 1.533B |
| Date | Value |
|---|---|
| September 30, 2024 | 1.542B |
| September 27, 2024 | 1.480B |
| September 26, 2024 | 1.412B |
| September 25, 2024 | 1.343B |
| September 24, 2024 | 1.310B |
| September 23, 2024 | 1.308B |
| September 20, 2024 | 1.357B |
| September 19, 2024 | 1.325B |
| September 18, 2024 | 1.303B |
| September 17, 2024 | 1.362B |
| September 16, 2024 | 1.379B |
| September 13, 2024 | 1.400B |
| September 12, 2024 | 1.379B |
| September 11, 2024 | 1.317B |
| September 10, 2024 | 1.254B |
| September 09, 2024 | 1.254B |
| September 06, 2024 | 1.233B |
| September 05, 2024 | 1.273B |
| September 04, 2024 | 1.249B |
| September 03, 2024 | 1.240B |
| August 30, 2024 | 1.369B |
| August 29, 2024 | 1.357B |
| August 28, 2024 | 1.362B |
| August 27, 2024 | 1.379B |
| August 26, 2024 | 1.400B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.3966M
Minimum
Feb 23 2022
2.130B
Maximum
Feb 09 2024
595.81M
Average
481.59M
Median
Jun 08 2020
Enterprise Value Benchmarks
| Verve Therapeutics Inc | -64.82M |
| United Therapeutics Corp | 13.90B |
| NovaBay Pharmaceuticals Inc | 3.645M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 9.837M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.809M |
| Revenue (Quarterly) | 98.24M |
| Total Expenses (Quarterly) | 96.01M |
| EPS Diluted (Quarterly) | -0.0034 |
| Gross Profit Margin (Quarterly) | 83.99% |
| Profit Margin (Quarterly) | -0.82% |
| Earnings Yield | -5.54% |
| Normalized Earnings Yield | -5.538 |